| 2918.99.18 | 00 | 4-(4-Chloro-2-methylphenoxy)butyric acid; p-Chlorophenoxyacetic acid; and 2-(2,4-Dichlorophenoxy)propionic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 40.5% |
| 2918.99.20 | 15 | 2-Methyl-4-chlorophenoxyacetic acid | kg | | | |
| 2921.22.10 | 00 | Derived in whole or in part from adipic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 3.4% (SG) | 15.4￠/kg + 66.5% |
| 2921.42.21 | 00 | Metanilic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, L,MA,MX,P) 0.1￠/kg + 3.3% (SG) | 15.4￠/kg + 60% |
| 2921.42.22 | 00 | Sulfanilic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.1￠/kg + 3.3% (SG) | 15.4￠/kg + 60% |
| 2921.59.20 | 00 | 4,4'-Diamino-2,2'-stilbenedisulfonic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 80% |
| 2922.49.40 | 15 | l-Aspartic acid | kg | | | |
| 2922.49.60 | 00 | 3-Aminocrotonic acid, methyl ester; and ￠/- α-Amino-1,4-cyclohexadiene-1- acetic acid | kg | Free | | 25% |
| 2924.23.10 | 00 | 2-Acetamidobenzoic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.29.05 | 00 | Biligrafin acid; 3,5-Diacetamido-2,4,6-triiodobenzoic acid; and Metrizoic acid | kg | 5.3% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 34% |
| 2930.90.49 | 10 | Thioglycolic acid | kg | | | |
| 2932.99.35 | 00 | 2-Hydroxy-3-dibenzofurancarboxylic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 66.5% |
| 2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.59.22 | 00 | Nicarbazin; and Trimethoprim | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 46% |
| 2933.69.60 | 15 | Sodium dichloroisocyanurate and trichloroisocyanuric acid | kg | | | |
| 2933.79.40 | 00 | 12-Aminododecanoic acid lactam | kg | Free | | 30.5% |
| 2934.99.70 | 00 | Morpholinoethyl chloride hydrochloride; 2-Methyl-2,5-dioxo-1-oxa-2-phospholan; and (6R-trans)-7-Amino-3-methyl-8-oxo-5- thia-1-azabicyclo[4.2.0]-oct-2-ene-2- carboxylic acid | kg | Free | | 30.5% |
| 2935.00.32 | 00 | Acetylsulfisoxazole; Sulfacetamide, sodium; and Sulfamethazine, sodium | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 96% |
| 2935.00.33 | 00 | Sulfathiazole and Sulfathiazole, sodium | kg | Free | | 15.4￠/kg + 133% |
| 2936.29.10 | 00 | Folic acid | kg | Free | | 15.4￠/kg + 49% |
| 2937.40.10 | 00 | l-Thyroxine (Levothyroxine), sodium | kg | Free | | 15.4￠/kg + 49% |
| 2941.10.30 | 00 | Carfecillin, sodium; Cloxacillin, sodium; Dicloxacillin, sodium; Flucloxacillin (Floxacillin); and Oxacillin, sodium | kg | Free | | 15.4￠/kg + 45% |
| 3002.10.01 | 20 | Normal human blood sera, whether or not freeze-dried | kg | | | |
| 3002.90.51 | 10 | Whole human blood | kg | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
